
   <?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 24 Apr 2026 06:34:05 -0400--><rss version="2.0">
    <channel>
        <title>Processa Pharmaceuticals, Inc. (PCSA) SEC Filings</title>
        <link>https://www.processapharmaceuticals.com/investors/sec-filings/annual-reports/rss</link>
        <description>Processa Pharmaceuticals, Inc. (PCSA) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png</url>
                <title>Processa Pharmaceuticals, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-10.20, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-011204/0001493152-26-011204.pdf</link>
                <pubDate>Wed, 18 Mar 26 16:08:12 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-26-011204/0001493152-26-011204.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[15 Related Documents: 10-K, EX-3.2, EX-10.11, EX-10.12, EX-10.13, EX-10.14, EX-10.15, EX-10.16, EX-19, EX-21.1, EX-23.1, EX-23.2, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001641172-25-000070/0001641172-25-000070.pdf</link>
                <pubDate>Thu, 20 Mar 25 16:34:58 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001641172-25-000070/0001641172-25-000070.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.4, EX-4.5, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-97.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-24-011976/0001493152-24-011976.pdf</link>
                <pubDate>Fri, 29 Mar 24 16:09:27 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-24-011976/0001493152-24-011976.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-23-014886/0001493152-23-014886.pdf</link>
                <pubDate>Mon, 01 May 23 10:03:03 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-23-014886/0001493152-23-014886.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-10.13, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-23-009730/0001493152-23-009730.pdf</link>
                <pubDate>Thu, 30 Mar 23 16:10:25 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-23-009730/0001493152-23-009730.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[3 Related Documents: 10-K/A, EX-31.1, EX-31.2]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-22-011777/0001493152-22-011777.pdf</link>
                <pubDate>Mon, 02 May 22 15:55:53 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-22-011777/0001493152-22-011777.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-4.4, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-22-008156/0001493152-22-008156.pdf</link>
                <pubDate>Wed, 30 Mar 22 16:07:48 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-22-008156/0001493152-22-008156.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[3 Related Documents: 10-K/A, EX-31.1, EX-31.2]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-21-008210/0001493152-21-008210.pdf</link>
                <pubDate>Wed, 07 Apr 21 16:24:54 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-21-008210/0001493152-21-008210.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.6, EX-10.15, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-21-006807/0001493152-21-006807.pdf</link>
                <pubDate>Thu, 25 Mar 21 20:49:35 -0400</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-21-006807/0001493152-21-006807.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-K, EX-23.1, EX-31.1, EX-32.1]]></description>
                <link>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-20-003534/0001493152-20-003534.pdf</link>
                <pubDate>Wed, 09 Dec 20 12:00:44 -0500</pubDate>
                <guid>https://www.processapharmaceuticals.com/investors/sec-filings/all-sec-filings/content/0001493152-20-003534/0001493152-20-003534.pdf</guid>
                                                                            </item>
            </channel>
</rss>